Understanding the Hidden Risk Factors Behind Heart Disease
Share
Heart disease remains a leading cause of death worldwide, but a new study offers fresh insight into three key blood markers that can help predict who is most at risk—even beyond cholesterol levels alone. The study, published in the European Heart Journal, focuses on LDL-cholesterol (LDL-C), lipoprotein(a) [Lp(a)], and high-sensitivity C-reactive protein (Hs-CRP).
What Are These Biomarkers?
- LDL-cholesterol (LDL-C): Often referred to as “bad” cholesterol, high levels can clog arteries and lead to heart attacks or strokes.
- Lipoprotein(a): A lesser-known type of cholesterol particle, Lp(a) is largely inherited and is not usually measured in routine tests. It can increase inflammation and blood clotting.
- High-sensitivity C-reactive protein (Hs-CRP): This is a marker of inflammation in the body. While it doesn’t cause heart disease directly, higher levels suggest inflammation that can damage blood vessels.
What Did the Study Find?
The study tracked over 322,000 people aged 38 to 73 for nearly 14 years. It found that each of these three markers independently increased the risk of major cardiovascular events—such as heart attacks, strokes, and surgeries to open blocked arteries.
Even more importantly, people with high levels of all three markers had a significantly greater risk of heart problems than those with lower levels. This was true even if they were already taking cholesterol-lowering medications.
The Numbers That Matter
Here’s a snapshot of the findings:
- A 13% increase in risk was linked to higher LDL-C levels.
- A 6–8% increase came from higher Lp(a) and Hs-CRP levels.
- People with all three markers elevated had up to a 77% higher risk of heart events if they weren’t on cholesterol-lowering drugs, and 58% higher risk even if they were.
These percentages reflect the risk per standard increase in each marker, showing that every little bit counts.
Why This Matters for You
Most people only know about LDL-C from standard cholesterol tests. However, Lp(a) and Hs-CRP are not typically measured, even though they play a major role in cardiovascular health.
Knowing your levels could help your doctor create a more complete picture of your heart risk—and decide if more aggressive treatment is needed, such as different medications or lifestyle changes.
What Can You Do?
- Ask for a full lipid panel: Especially if you have a family history of heart disease, ask your doctor to test Lp(a) and Hs-CRP in addition to standard cholesterol.
- Adopt anti-inflammatory habits: Eat more fruits, vegetables, whole grains, and healthy fats. Limit processed food and sugar, which can raise inflammation.
- Stay active: Regular physical activity helps lower LDL and reduce inflammation.
- Don’t smoke and limit alcohol: These can worsen all three markers.
If needed, medications like statins, PCSK9 inhibitors, or anti-inflammatory drugs may be recommended. New treatments for lowering Lp(a) are also being researched.
The Bottom Line
This study shows that heart disease risk isn’t just about LDL cholesterol. It’s a combination of cholesterol and inflammation, with Lp(a) playing a unique role. Measuring and managing all three—LDL-C, Lp(a), and Hs-CRP—could be the key to preventing serious heart problems before they start.